News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Temodal To Be Funded For Brain Cancer Patients

Temodal To Be Funded For Newly Diagnosed Brain Cancer Patients

Auckland: Schering Plough is pleased to announce that its brain cancer treatment Temodal (temozolomide) has reached the final stages of funding negotiations with PHARMAC.

Tim Jones, New Zealand Director, Schering Plough, explained that the company is delighted that funding for this important treatment will open up access to Temodal for newly diagnosed Glioblastoma Multiforme (GBM) patients in New Zealand.

"We worked closely with PHARMAC to ensure that Temodal will soon become available for patients with this very aggressive form of brain cancer. Today we reached the final stage of an agreement with PHARMAC and a standard consultation letter has been issued to the market. We hope to see Temodal funded for GBM patients as early as May 2006."

GBM is the most common brain cancer in adults. Over 100 people are diagnosed with GBM in New Zealand annually. It progresses quickly and is for the majority of patients it is terminal.

"The percentage of Temodal-treated patients surviving for two years after diagnosis is almost two and a half times that of patients who are treated with radiotherapy alone. Temodal is the most significant development in the treatment of newly diagnosed brain cancers in 30 years, since radiation treatment was first introduced."


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines

Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>

Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>


Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>